Kathleen P. Bloch - May 25, 2023 Form 4 Insider Report for Cytosorbents Corp (CTSO)

Role
Interim CFO
Signature
/s/ Kathleen P. Bloch
Stock symbol
CTSO
Transactions as of
May 25, 2023
Transactions value $
$9,389
Form type
4
Date filed
5/30/2023, 07:30 AM
Previous filing
May 12, 2023
Next filing
Jul 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTSO Common Stock Purchase $3.13K +1.1K +2.52% $2.85 44.8K May 25, 2023 See footnote F1
transaction CTSO Common Stock Purchase $3.12K +1.1K +2.46% $2.84 45.9K May 25, 2023 See footnote F1
transaction CTSO Common Stock Purchase $3.13K +1.1K +2.4% $2.85 47K May 25, 2023 See footnote F1
holding CTSO Common Stock 397K May 25, 2023 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held by the Reporting Person's husband in a 401(k) account. The Reporting Person may be deemed the beneficial owner of such shares.
F2 Includes: (i) the following RSUs that will be settled into Common Stock upon a "Change In Control" of CytoSorbents Corporation (the "Company"), as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 8,800 RSUs granted on March 15, 2018, (b) 15,700 RSUs granted on February 24, 2017, (c) 47,000 RSUs granted on June 7, 2016 and (d) 110,000 RSUs granted on April 8, 2015;
F3 (continued from footnote 2) (ii) the following RSUs (which vest as to one-third of the award on each of the date of grant, the first anniversary of the date of grant, and the second anniversary of the date of grant, subject to the Reporting Person's continued service as of the applicable vesting date), and will be settled into common stock of the Company upon vesting: 37,000 RSUs granted on August 10, 2022; and
F4 (continued from footnote 3) (iii) 178,847 shares of Common Stock owned by the Reporting Person.